ABT - Abbott Laboratories - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0028241000

Pharmaceuticals, Diagnostics, Nutritionals, Medical Devices

A leading healthcare company, Abbott Laboratories, along with its subsidiaries, is dedicated to discovering, developing, manufacturing, and distributing a wide range of healthcare products globally.

The company operates through four key segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its pharmaceutical portfolio includes generic medications for treating various health conditions, such as pancreatic exocrine insufficiency, irritable bowel syndrome, and hormone replacement therapy, among others. Additionally, it offers anti-infective medications, influenza vaccines, and products that regulate the physiological rhythm of the colon.

In the diagnostics space, Abbott provides a comprehensive range of products and systems, including laboratory and transfusion medicine systems, molecular diagnostics, point-of-care systems, and rapid diagnostics lateral flow testing products. These solutions enable healthcare professionals to detect and measure infectious agents, test for various health conditions, and monitor patients remotely.

The company's nutritional products cater to both pediatric and adult needs, offering a range of formulas and supplements for healthy growth and development. Its medical devices segment includes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for cardiovascular diseases, as well as diabetes care products, such as glucose and blood glucose monitoring systems. Furthermore, Abbott offers neuromodulation devices for managing chronic pain and movement disorders.

With a rich history dating back to 1888, Abbott Laboratories is headquartered in North Chicago, Illinois, and continues to innovate and expand its product portfolio to improve healthcare outcomes worldwide. For more information, visit https://www.abbott.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for ABT - Abbott Laboratories  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for ABT - Abbott Laboratories  - Stock Price & Dividends

ABT Stock Overview

Market Cap in USD 177,494m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1978-01-13

ABT Stock Ratings

Growth 5y 22.6
Fundamental 50.0
Dividend 65.6
Rel. Performance vs Sector -1.32
Analysts 4.25/5
Fair Price Momentum 98.40 USD
Fair Price DCF 74.60 USD

ABT Dividends

Dividend Yield 12m 2.05%
Yield on Cost 5y 2.66%
Dividends CAGR 5y 9.77%
Payout Consistency 96.8%

ABT Growth Ratios

Growth 12m -4.70%
Growth Correlation 12m 18%
Growth Correlation 3m -21%
CAGR 5y 5.31%
CAGR/Mean DD 5y 0.39
Sharpe Ratio 12m -0.55
Alpha vs SP500 12m -22.44
Beta vs SP500 5y weekly 0.80
ValueRay RSI 70.08
Volatility GJR Garch 1y 23.15%
Price / SMA 50 1.7%
Price / SMA 200 -0.48%
Current Volume 8472.4k
Average Volume 20d 7011.4k

External Links for ABT Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of ABT stocks?
As of July 27, 2024, the stock is trading at USD 105.24 with a total of 8,472,379 shares traded.
Over the past week, the price has changed by +3.15%, over one month by +0.88%, over three months by -1.61% and over the past year by -3.50%.
What are the forecast for ABT stock price target?
According to ValueRays Forecast Model, ABT Abbott Laboratories will be worth about 108.5 in July 2025. The stock is currently trading at 105.24. This means that the stock has a potential upside of +3.07%.
Issuer Forecast Upside
Wallstreet Target Price 124.8 18.6
Analysts Target Price 110.7 5.14
ValueRay Target Price 108.5 3.07

Abbott Laboratories: A Comprehensive Overview

The History of Abbott Laboratories

Founded by Dr. Wallace C. Abbott in 1888, Abbott Laboratories started as a small pharmaceutical operation in Chicago. Its inception was marked by the innovative approach of Dr. Abbott, who began by formulating known drugs into tiny, easy-to-use pills. This was a significant departure from traditional practices, setting the stage for a legacy of innovation. Over the decades, Abbott expanded its reach, not just in pharmaceuticals, but also into diagnostics, medical devices, and nutrition, thereby solidifying its place in the healthcare industry.

Core and Side Businesses

Abbott Laboratories operates through four main business segments:

  • Diagnostics: Offers a wide range of diagnostic systems and tests for detection of diseases.
  • Medical Devices: This comprises cardiovascular devices and diabetes care products that help people manage their health effectively.
  • Nutrition: Nutrition segment produces infant formulas, nutritional products for children, and dietetic foods.
  • Branded Generic Pharmaceuticals: Provides a broad line of branded, generic pharmaceuticals, primarily in emerging markets.

Aside from these core segments, Abbott has also ventured into other areas through strategic acquisitions, technology advancements, and research initiatives, which further diversify its operations and strengthen its market position.

Current Market Status

Today, Abbott Laboratories is recognized as a global leader in healthcare, with its products reaching millions across the world. The company's commitment to innovation has powered its growth, with significant investments in research and development. Financially, Abbott has demonstrated robust performance, with steady revenue growth and a strong stock market presence, showcasing its resilience and adaptability in the face of changing market dynamics. As of 2023, Abbott continues to expand its global reach and impact, staying true to its mission of providing cutting-edge, accessible healthcare solutions.